 Home > Biochemistry News > Biotechnology News > The first in 5 years!

The first in 5 years!

 Last Update: 2021-11-01
 Source: Internet
 Author: User

Tags

phosphorus side effects

1 10 phenanthroline

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On the 23rd, Roche announced that the US FDA has approved Susvimo for the treatment of patients with wet age-related macular degeneration (AMD)

Wet AMD is the main cause of vision loss in people over 60 years old, and there are approximately 20 million patients worldwide

The current standard treatment is to inject anti-VEGF antibody drugs into the eye.

Susvimo implants a transplant that can be regularly refilled with medication in the patient's eye.

▲Introduction to Susvimo (picture source: Roche official website)

This approval is based on the positive results of a pivotal, randomized, double-blind, multi-center, open-label Phase 3 clinical trial

Reference materials:

[1] FDA approves Roche's Susvimo, a first-of-its-kind therapeutic approach for neovascular or “wet” age-related macular degeneration (nAMD).

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Negative growth for the first time in the past 5 years!

08-13

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.

The first in 5 years!

Related Articles

Negative growth for the first time in the past 5 years!